CLVS1

 

Full name: clavesin 1 Alias Symbol: MGC34646|CRALBPL|C6orf212L
Type: protein-coding gene Cytoband: 8q12.2-q12.3
Entrez ID: 157807 HGNC ID: HGNC:23139 Ensembl Gene: ENSG00000177182 OMIM ID: 611292
Drug and gene relationship at DGIdb

 

Expression of CLVS1:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 CLVS1 157807 230217_at -0.1893 0.3242
GSE26886 CLVS1 157807 230217_at -0.2516 0.0714
GSE45670 CLVS1 157807 230217_at -0.0696 0.4661
GSE63941 CLVS1 157807 230217_at 0.2177 0.2405
GSE77861 CLVS1 157807 230217_at -0.1323 0.3146
SRP007169 CLVS1 157807 RNAseq -7.1905 0.0000
SRP064894 CLVS1 157807 RNAseq -2.8206 0.0000
SRP133303 CLVS1 157807 RNAseq -1.2969 0.0428
TCGA CLVS1 157807 RNAseq -0.0603 0.8703

Upregulated datasets: 0; Downregulated datasets: 3.  


 

Survival by CLVS1 expression:

 

TCGA

 

Note: Click image to view full size file.  


Copy number change of CLVS1:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 CLVS1 157807 13 1 16
GSE20123 CLVS1 157807 13 1 16
GSE43470 CLVS1 157807 14 3 26
GSE46452 CLVS1 157807 20 2 37
GSE47630 CLVS1 157807 23 1 16
GSE54993 CLVS1 157807 1 18 51
GSE54994 CLVS1 157807 30 0 23
GSE60625 CLVS1 157807 0 4 7
GSE74703 CLVS1 157807 12 2 22
GSE74704 CLVS1 157807 9 0 11
TCGA CLVS1 157807 45 6 45

Total number of gains: 180; Total number of losses: 38; Total Number of normals: 270.  


 

Somatic mutations of CLVS1:

 

Generating mutation plots.

 

Highly correlated genes for CLVS1:

 

Showing top 20/101 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
CLVS1CRB30.714084303
CLVS1ATP6V0C0.698473303
CLVS1ZNF1350.693755303
CLVS1NAPA0.691668303
CLVS1TJP20.688364303
CLVS1NDUFS70.686583404
CLVS1LINC011340.660282303
CLVS1CLDN170.658158303
CLVS1GPR820.65624303
CLVS1SEC14L50.652916303
CLVS1LCN80.651006303
CLVS1PHF70.648117403
CLVS1C10orf670.647484303
CLVS1MYBPC30.640582303
CLVS1KIF250.63868403
CLVS1KRT360.638638303
CLVS1ALKBH70.635272303
CLVS1GOT10.633452303
CLVS1FAM71C0.633029303
CLVS1ANKRD30B0.627846403

For details and further investigation, click here